In moribund mice, we find that 19.5±2.4% of CD3+ brain lymphocytes expressed OX40.
During the symptomatic effector phase of ECM, we found that 13.68% and 84.34% of CD3+ brain lymphocytes were CD4+CD8− and CD4−CD8+ T cells, respectively (Fig. 6A).
Conversely, although 84.34% of CD3+ brain lymphocytes were CD8+ T cells, only 7.59% of these CD8+ T cells expressed OX40 (Fig. 6C).
In mice exhibiting symptoms of ECM, 13.68% and 84.34% of CD3+ brain lymphocytes were CD4+ and CD8+ T cells, respectively (Fig. 6A).
This reduction in OX40+ brain lymphocytes is most likely a consequence of the significantly fewer CD3+ lymphocytes observed in the brain of non-moribund (1592±800) compared to moribund (13,072±3881) mice.
[69] This role is unlikely to be as important in the brain during acute infection, which is marked by low numbers of brain lymphocytes and low proportions of CTLs and NKs [70].
HAART is now linked to an increased production of brain lymphocytes that lead to a transient motor-cognitive disorder that looks like amyotrophic lateral sclerosis.
However, it is now revealed that PRL is able to exert its effects on additional cells and tissues (decidual cells of the placenta, bone, brain, lymphocytes and breast epithelial cells) [ 6, 7].
All FPKM values for 5 human tissue-types (brain, liver, lymphocyte, lymphocyte XM, and lymphocyte XP) were filtered based on the GO-term of interest by mining the on-line AMIGO database for gene names associated with each Biological Process term of interest.
Focal gliosis occurred occasionally in the brain, with lymphocyte infiltration under cranial arachnoid (Fig. 3D).
